Process for the preparation of N- (3,5-dichloropyrid-4-yl)-4difluoromethox y8-methanesulfonamido-dibenzo[b,d]fura n-1-carboxamide

Details for Australian Patent Application No. 2005293293 (hide)

Owner Glenmark Pharmaceuticals S.A.

Inventors Pillai, Bijukumar Gopinathan; Chandrasekhar, Batchu; Gopalan, Balasubramanian; Gharat, Laxmikant Atmaram; Karaunakaran, Usha

Agent Davies Collison Cave

Pub. Number AU-A-2005293293

PCT Pub. Number WO2006/040652

Priority 60/618,474 13.10.04 US; 60/621,981 21.10.04 US; 1099/MUM/2004 14.10.04 IN

Filing date 12 October 2005

Wipo publication date 20 April 2006

International Classifications

C07C 201/12 (2006.01) Compounds containing carbon and nitrogen with or without hydrogen, halogens or oxygen

C07C 205/38 (2006.01) Compounds containing nitro groups bound to a carbon skeleton

C07D 307/91 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

3 May 2007 PCT application entered the National Phase

  PCT publication WO2006/040652 Priority application(s): WO2006/040652

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293303-Statistical analysis in pattern recognition, in particular in fingerprint recognition

2005293290-Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydr oxyethyl)-4-methylbenzamide